190 related articles for article (PubMed ID: 27031528)
41. Trans-scleral local resection of toxic choroidal melanoma after proton beam radiotherapy.
Konstantinidis L; Groenewald C; Coupland SE; Damato B
Br J Ophthalmol; 2014 Jun; 98(6):775-9. PubMed ID: 24568869
[TBL] [Abstract][Full Text] [Related]
42. Photodynamic therapy for symptomatic subretinal fluid related to choroidal nevus.
García-Arumí J; Amselem L; Gunduz K; Badal J; Adan A; Zapata MA; Valldeperas X; Huste F; Corcóstegui B
Retina; 2012 May; 32(5):936-41. PubMed ID: 22366902
[TBL] [Abstract][Full Text] [Related]
43. Proton beam irradiation using a light-field technique for the treatment of choroidal hemangiomas.
Chan RV; Yonekawa Y; Lane AM; Skondra D; Munzenrider JE; Collier JM; Gragoudas ES; Kim IK
Ophthalmologica; 2010; 224(4):209-16. PubMed ID: 19940527
[TBL] [Abstract][Full Text] [Related]
44. Pars plana lensectomy and intraocular lens implantation in pediatric radiation-induced cataracts in retinoblastoma.
Miller DM; Murray TG; Cicciarelli NL; Capo H; Markoe AM
Ophthalmology; 2005 Sep; 112(9):1620-4. PubMed ID: 16024083
[TBL] [Abstract][Full Text] [Related]
45. Long-term results after low dose ocular irradiation for choroidal haemangiomas.
Schilling H; Sauerwein W; Lommatzsch A; Friedrichs W; Brylak S; Bornfeld N; Wessing A
Br J Ophthalmol; 1997 Apr; 81(4):267-73. PubMed ID: 9215052
[TBL] [Abstract][Full Text] [Related]
46. Low dose ocular irradiation for diffuse choroidal hemangiomas associated with bullous nonrhegmatogenous retinal detachment.
Scott TA; Augsburger JJ; Brady LW; Hernandez C; Woodleigh R
Retina; 1991; 11(4):389-93. PubMed ID: 1813954
[TBL] [Abstract][Full Text] [Related]
47. Short-term safety and efficacy of intravitreal bevacizumab for pseudophakic cystoid macular edema.
Barone A; Russo V; Prascina F; Delle Noci N
Retina; 2009 Jan; 29(1):33-7. PubMed ID: 18854783
[TBL] [Abstract][Full Text] [Related]
48. OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF THE MACULA AFTER PLAQUE RADIOTHERAPY OF CHOROIDAL MELANOMA: Comparison of Irradiated Versus Nonirradiated Eyes in 65 Patients.
Shields CL; Say EA; Samara WA; Khoo CT; Mashayekhi A; Shields JA
Retina; 2016 Aug; 36(8):1493-505. PubMed ID: 26960015
[TBL] [Abstract][Full Text] [Related]
49. Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.
Goff MJ; Johnson RN; McDonald HR; Ai E; Jumper JM; Fu A
Retina; 2007; 27(4):432-8. PubMed ID: 17420694
[TBL] [Abstract][Full Text] [Related]
50. Subfoveal choroidal thickness after ranibizumab therapy for neovascular age-related macular degeneration: 12-month results.
Yamazaki T; Koizumi H; Yamagishi T; Kinoshita S
Ophthalmology; 2012 Aug; 119(8):1621-7. PubMed ID: 22551738
[TBL] [Abstract][Full Text] [Related]
51. Efficacy of proton therapy in circumscribed choroidal hemangiomas associated with serious retinal detachment.
Hannouche D; Frau E; Desjardins L; Cassoux N; Habrand JL; Offret H
Ophthalmology; 1997 Nov; 104(11):1780-4. PubMed ID: 9373107
[TBL] [Abstract][Full Text] [Related]
52. Choroidal lymphoma: clinical features and association with systemic lymphoma.
Mashayekhi A; Shukla SY; Shields JA; Shields CL
Ophthalmology; 2014 Jan; 121(1):342-351. PubMed ID: 23978622
[TBL] [Abstract][Full Text] [Related]
53. The relationship between retinal and choroidal thickness and visual acuity in highly myopic eyes.
Flores-Moreno I; Ruiz-Medrano J; Duker JS; Ruiz-Moreno JM
Br J Ophthalmol; 2013 Aug; 97(8):1010-3. PubMed ID: 23766433
[TBL] [Abstract][Full Text] [Related]
54. Intravitreal bevacizumab for subfoveal idiopathic choroidal neovascularization.
Mandal S; Garg S; Venkatesh P; Mithal C; Vohra R; Mehrotra A
Arch Ophthalmol; 2007 Nov; 125(11):1487-92. PubMed ID: 17998509
[TBL] [Abstract][Full Text] [Related]
55. Three-year follow-up of a pilot study of ranibizumab combined with proton beam irradiation as treatment for exudative age-related macular degeneration.
Park SS; Daftari I; Phillips T; Morse LS
Retina; 2012 May; 32(5):956-66. PubMed ID: 22183743
[TBL] [Abstract][Full Text] [Related]
56. Endoresection technique with/without brachytherapy for management of high posterior choroidal melanoma: extended follow-up results.
Garcia-Arumi J; Leila M; Zapata MA; Velázquez D; Dinares-Fernandez MC; Tresserra F; Corcostegui B
Retina; 2015 Apr; 35(4):628-37. PubMed ID: 25462434
[TBL] [Abstract][Full Text] [Related]
57. Postoperative posterior segment complications in eyes treated with the Boston type I keratoprosthesis.
Goldman DR; Hubschman JP; Aldave AJ; Chiang A; Huang JS; Bourges JL; Schwartz SD
Retina; 2013 Mar; 33(3):532-41. PubMed ID: 23073339
[TBL] [Abstract][Full Text] [Related]
58. Plaque radiotherapy for juxtapapillary choroidal melanoma: treatment complications and visual outcomes in 650 consecutive cases.
Sagoo MS; Shields CL; Emrich J; Mashayekhi A; Komarnicky L; Shields JA
JAMA Ophthalmol; 2014 Jun; 132(6):697-702. PubMed ID: 24652552
[TBL] [Abstract][Full Text] [Related]
59. Assessment of central vision and macular structure in patients undergoing iodine-125 brachytherapy for ciliochoroidal melanoma.
Oliver SC; Young TA; Kobe LH; Leu MY; Lee SP; Chun MW; Straatsma BR
Am J Clin Oncol; 2008 Oct; 31(5):488-92. PubMed ID: 18838887
[TBL] [Abstract][Full Text] [Related]
60. Long-term follow-up of surgical removal of extensive peripapillary choroidal neovascularization in presumed ocular histoplasmosis syndrome.
Almony A; Thomas MA; Atebara NH; Holekamp NM; Del Priore LV
Ophthalmology; 2008 Mar; 115(3):540-545.e5. PubMed ID: 17988741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
